Efficacy and Safety of Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure: A Single-arm, Open-label, Multicenter Phase II Clinical Study
Latest Information Update: 28 Mar 2024
At a glance
- Drugs Cadonilimab (Primary) ; Catequentinib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
Most Recent Events
- 28 Mar 2024 New trial record